Bobin Ning
Overview
Explore the profile of Bobin Ning including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ning B, Chi J, Meng Q, Jia B
Sci Rep
. 2024 Dec;
14(1):29882.
PMID: 39622880
Colorectal cancer (CRC) ranks as the third most prevalent tumor and the second leading cause of mortality. Early and accurate diagnosis holds significant importance in enhancing patient treatment and prognosis....
2.
Chi J, Xue Y, Zhou Y, Han T, Ning B, Cheng L, et al.
ACS Nano
. 2024 Aug;
18(35):24295-24305.
PMID: 39164203
Accurately distinguishing tumor cells from normal cells is a key issue in tumor diagnosis, evaluation, and treatment. Fluorescence-based immunohistochemistry as the standard method faces the inherent challenges of the heterogeneity...
3.
Wang W, Meng Q, Cheng Y, Han Y, Xue Y, Kuang Y, et al.
Cancers (Basel)
. 2023 Jan;
15(1).
PMID: 36612087
Background: Immunodeficiency diseases (IDDs) are associated with an increased proportion of cancer-related morbidity. However, the relationship between IDDs and malignancy readmissions has not been well described. Understanding this relationship could...
4.
Cao Y, Ning B, Tian Y, Lan T, Chu Y, Ren F, et al.
Cancers (Basel)
. 2022 Oct;
14(19).
PMID: 36230720
Histone deacetylases 1 (HDAC1), an enzyme that functions to remove acetyl molecules from ε-NH3 groups of lysine in histones, eliminates the histone acetylation at the promoter regions of tumor suppressor...
5.
Xue Y, Ning B, Liu H, Jia B
BMC Gastroenterol
. 2022 Mar;
22(1):127.
PMID: 35300596
Background: Colon cancer remains one of the most common malignancies across the world. Thus far, a biomarker, which can comprehensively predict the survival outcomes, clinical characteristics, and therapeutic sensitivity, is...
6.
Guo Y, Ning B, Zhang Q, Ma J, Zhao L, Lu Q, et al.
Int J Gen Med
. 2022 Jan;
15:623-635.
PMID: 35058712
Purpose: The objective of this study was to identify the potential regulatory mechanisms, diagnostic biomarkers, and therapeutic drugs for heart failure (HF). Methods: Differentially expressed genes (DEGs) between HF and...
7.
Gong X, Ning B
Technol Cancer Res Treat
. 2020 Oct;
19:1533033820963578.
PMID: 33084528
Prostate cancer (PCa) is a highly malignant tumor, with increasing incidence and mortality rates worldwide. The aim of this study was to identify the prognostic lncRNAs and construct an lncRNA...